In numerous cell types, it promotes cell-cycle progression from G1 to S. USP2 becomes active or overexpressed in several cancers, such as mantle cell lymphoma, a subtype of non-Hodgkin’s lymphoma. This evidence concerns the gene USP2 and non-Hodgkin lymphoma.